Fenouille, N., Bassil, C. F., Ben-Sahra, I., Benajiba, L., Alexe, G., Ramos, A., . . . Stegmaier, K. (2017). The creatine kinase pathway is a metabolic vulnerability in EVI1-positive acute myeloid leukemia. Nature medicine, 23(3), 301-313. https://doi.org/10.1038/nm.4283
Chicago Style (17th ed.) CitationFenouille, Nina, et al. "The Creatine Kinase Pathway Is a Metabolic Vulnerability in EVI1-positive Acute Myeloid Leukemia." Nature Medicine 23, no. 3 (2017): 301-313. https://doi.org/10.1038/nm.4283.
MLA (9th ed.) CitationFenouille, Nina, et al. "The Creatine Kinase Pathway Is a Metabolic Vulnerability in EVI1-positive Acute Myeloid Leukemia." Nature Medicine, vol. 23, no. 3, 2017, pp. 301-313, https://doi.org/10.1038/nm.4283.
Warning: These citations may not always be 100% accurate.